Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Revenue (2016 - 2025)

INVO Fertility has reported Revenue over the past 15 years, most recently at $1.8 million for Q3 2025.

  • Quarterly Revenue rose 22.6% to $1.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Sep 2025, up 11.5% year-over-year, with the annual reading at $6.5 million for FY2024, 116.25% up from the prior year.
  • Revenue was $1.8 million for Q3 2025 at INVO Fertility, down from $1.9 million in the prior quarter.
  • Over five years, Revenue peaked at $3.0 million in Q4 2021 and troughed at $146135.0 in Q2 2022.
  • The 5-year median for Revenue is $974894.0 (2023), against an average of $1.0 million.
  • Year-over-year, Revenue skyrocketed 1450.7% in 2021 and then plummeted 90.88% in 2022.
  • A 5-year view of Revenue shows it stood at $3.0 million in 2021, then plummeted by 90.88% to $278142.0 in 2022, then soared by 396.78% to $1.4 million in 2023, then increased by 22.02% to $1.7 million in 2024, then rose by 4.22% to $1.8 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Revenue are $1.8 million (Q3 2025), $1.9 million (Q2 2025), and $1.6 million (Q1 2025).